Skip to main content

Nonprofit · EIN 46-2829156

CURE LBSL

Tax-exempt · ARLINGTON, VA 22206

Financials

$1.9M$1.7M2023$1.1M$845K2024$652K$307K2025
Revenue Expenses · by fiscal year end
Financials of CURE LBSL by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2025990$651,672$307,430$344,242$1,315,374$0$1,315,374
December 31, 2024990 (amended)$1,052,682$845,152$207,530$955,625$0$955,625
December 31, 2023990$1,852,552$1,661,665$190,887$739,400$0$739,400
Financial details: 990 for the year ended December 31, 2025

Revenue

Contributions, gifts and grants
$629,886
Program service revenue
$0
Investment income
$21,786
Other revenue
$0

Expenses

Grants and similar amounts paid
$123,984
Compensation of officers, directors and key employees
$50,000
Other salaries and wages
$2,250
Salaries, compensation and benefits (total)
$52,250
Professional fundraising fees
$0
Accounting fees
$1,480
Travel
$8,474
Program services (functional)
$307,430

Balance sheet and other

Total assets, start of year
$958,132
Total assets, end of year
$1,315,374
Total liabilities, end of year
$0
Net assets, end of year
$1,315,374
Net assets without donor restrictions
$942,707
Net assets with donor restrictions
$372,667
Gross receipts
$651,672
Employees
0
Volunteers
10
Year formed
2013
State of legal domicile
VA

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2025, highest compensation first.

NameTitleHours / weekCompensation
MORGAN VOIGTEXECUTIVE DIRECTOR
Trustee or director
30$50,000
LANCE STERNDIRECTOR
Trustee or director
1$0
MEGAN MITCHELLDIRECTOR
Trustee or director
1$0
CHRIS GULUGIANDIRECTOR
Trustee or director
1$0
EDWARD BLAKELYDIRECTOR
Trustee or director
1$0
ELIZABETH MCGINNDIRECTOR
Trustee or director, Officer
15$0
ELIZABETH GULUGIANBOARD CHAIR
Trustee or director, Officer
5$0
MORGAN STERNDIRECTOR
Trustee or director
1$0
990 for the year ended December 31, 2024: 8 people
NameTitleHours / weekCompensation
MORGAN STERNDIRECTOR
Trustee or director
1$0
LANCE STERNDIRECTOR
Trustee or director
1$0
MEGAN MITCHELLDIRECTOR
Trustee or director
1$0
CHRIS GULUGIANDIRECTOR
Trustee or director
1$0
EDWARD BLAKEYDIRECTOR
Trustee or director
1$0
MICHAEL MCGINN UNTIL 724DIRECTOR
Trustee or director
1$0
ELIZABETH A MCGINNDIRECTOR
Trustee or director, Officer
15$0
ELIZABETH GULUGIANBOARD CHAIR
Trustee or director, Officer
5$0
990 for the year ended December 31, 2023: 8 people
NameTitleHours / weekCompensation
Morgan SternDirector
Trustee or director
1$0
Lance SternDirector
Trustee or director
1$0
Megan MitchellDirector
Trustee or director
1$0
Chris GulugianDirector
Trustee or director
1$0
Edward BlakelyDirector
Trustee or director
1$0
Michael McGinn until 724Director
Trustee or director
1$0
Elizabeth A McGinnDirector
Trustee or director, Officer
15$0
Elizabeth GulugianBoard Chair
Trustee or director, Officer
5$0

Address and contacts

Address (IRS master file)
3520 S WAKEFIELD ST, ARLINGTON, VA 22206-1708
In care of
% LANCE STERN
Mailing address (990-N for 2016)
4414 36TH ST S, Arlington VA 22206
Principal officer (990 for 2025)
Morgan Voigt, 2403 Pond Rd, Kailua, HI 96734
Principal officer (990-N for 2016)
Michael McGinn, 4414 36TH ST S, Arlington VA 22206
Signed the 990
Morgan Voigt, Executive Director
Phone
(202) 487-4235

Mission

PROVIDE FUNDING TO RARE DISEASE RESEARCH AND SUPPORT AFFECTED FAMILIES

990 for the year ended December 31, 2025

Program accomplishments

  • Cure LBSL's primary mission is to fund critical research into Leukoencephalopathy with Brain Stem and Spinal Cord Involvement and Lactate Elevation (LBSL), a rare genetic leukodystrophy. During 2025, the organization supported research initiatives designed to improve understanding of the disease, advance scientific knowledge of disease progression, and explore potential therapeutic approaches. Activities included support for natural history and qualitative patient studies as well as collaborations with academic and clinical research partners.
    Expenses $214,629 · grants $141,768
  • Cure LBSL conducted an Externally-Led Patient Focused Drug Development meeting on August 1, 2025. This advocacy initiative gathered patient and caregiver perspectives regarding the impact of LBSL and provided information intended to support regulatory and therapeutic development efforts.
    Expenses $92,801

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026990 on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
46-2829156
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
2013
Accounting year ends
December
Files
Form 990 or 990-EZ
Assets (IRS master file)
$1,315,374
Income (IRS master file)
$651,672

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2025$651,672$307,430$1,315,374XML
990December 2024$1,052,682$845,152$955,625XML
990December 2023$1,852,552$1,661,665$739,400XML
990December 2022$1,410,138$1,319,933$535,129IRS
990December 2021–––IRS
990December 2020–––IRS
990December 2019–––IRS
990December 2018–––IRS
990-EZDecember 2017–––IRS
990-N for 2016
Officer: Michael McGinn
December 31, 2016≤ $50,000 receipts––e-Postcard

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 46-2829156).

Questions about CURE LBSL

What is the EIN of CURE LBSL?
The employer identification number (EIN) of CURE LBSL is 46-2829156.
Is CURE LBSL tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2013.
Are donations to CURE LBSL tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does CURE LBSL file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of CURE LBSL due?
The return for tax year 2026 (the year ending December 31, 2026) is due May 17, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
When did CURE LBSL last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2025.
Who is the principal officer of CURE LBSL?
The 990 for the year ended December 31, 2025 names Morgan Voigt.
Who are the officers and directors of CURE LBSL?
The 990 for the year ended December 31, 2025 lists 8 people; 1 received compensation from the organization, the highest $50,000 (MORGAN VOIGT, EXECUTIVE DIRECTOR).
How much revenue does CURE LBSL have?
On its 990 for the year ended December 31, 2025 it reported revenue of $651,672, expenses of $307,430 and total assets of $1,315,374 at year end.

Other nonprofits in ARLINGTON

All nonprofits in ARLINGTON · Virginia · Voluntary health associations and medical disciplines